Lung cancer patients
-
Evaluate the initial treatment results of non-small cell lung cancer with EGFR and ALK concurrent mutations. Subjects and methods: A prospective study, non-controlled description, and longitudinal follow-up of 6 patients with stage IIIB-IV non-small cell lung cancer, with EGFR and ALK concurrent mutations, at the National Lung Hospital, from January 2022 to July 2023.
5p vipanly 28-10-2024 0 0 Download
-
To evaluate the outcomes of whole-brain radiotherapy (WBRT) in patients with brain metastases from non-lung cancer at Viet Tiep Friendship Hospital between January 2022 and December 2023.
5p vibecca 01-10-2024 2 2 Download
-
The study aimed to evaluate the cachexia status and its associated factors in lung cancer patients. Methods: The cross-sectional study was conducted on 97 lung cancer in patients at the Oncology Center, Military Hospital 103, between 2020 and 2021.
10p viyoko 20-09-2024 4 1 Download
-
To evaluate the effectiveness of radiotherapy on overall survival (OS) and identify factors affecting survival outcomes in patients with stage III non-small cell lung cancer (NSCLC) where surgery is not feasible.
11p viavatis 29-08-2024 4 1 Download
-
Vinorelbine monotherapy has been shown to be effective in recurrent or metastatic non-small cell lung cancer. This study aimed at evaluating the treatment results of vinorelbine monotherapy in lung cancer patients relapsed after curative treatment.
7p vinatisu 29-08-2024 1 0 Download
-
Analysis of EGFR gene mutation in patients with non - small cell lung cancer in Hue Central Hospital
To analyze the EGFR mutation index on the cancer blocs of the patients with non - small cell lung cancer (NSCLC) at the Department of Pathology - Hue Central Hospital. A prospective, cross-sectional descriptive study of 227 patients with advanced, metastatic non - small cell lung cancer who were mutated in the EGFR gene. The study were carried out on the cancer parrafin blocs stored in Pathology Department, Hue Central Hospital.
5p vinatisu 29-08-2024 0 0 Download
-
Assess clinical, subclinical characteristics of stage IB-IIIA non - small cell lung cancer patients (NSCLC). Evaluating the result of adjuvant vinorelbine plus cisplatin in completely resected stage IB - IIIA NSCLC.
6p vinatisu 29-08-2024 2 0 Download
-
Depression and anxiety are common problems of cancer patients. They affect importantly the patients’ health, the decision to be treated, and the outcome of the treatment. This study aimed to assess the prevalence of depression and anxiety among cancer patients being treated at Hue University Hospital in 2019 and to reveal its correlation factors.
6p vinatisu 29-08-2024 8 1 Download
-
The global rise in aging population led to the increase of the number of elderly patients with lung cancer. Due to the impairment of the function of multiple organs, the work-up and treatment NSCLC for older patients become more difficult than adults.
5p vinatisu 29-08-2024 5 1 Download
-
The aim of this study was to evaluate the outcomes of initial Paclitaxel - Carboplatin (TC) treatment in patients with advanced non - small cell lung cancer. A total of 38 patients diagnosed with de novo NSCLC stage from IIIB to IV were underwent TC regimen from 2 to 6 cycles between February 2021 and July 2022 at Hue university of medicine and pharmacy hospital and Hue central hospital.
6p vinatisu 29-08-2024 4 1 Download
-
Brain metastasis is common in patients with non-small cell lung cancer (NSCLC) and it is associated with poorer prognosis. Several options to control the secondary brain tumors in the context include chemotherapy, whole-brain radiation, stereotactic surgery, surgery. However, chemotherapy is ineffective to those patients because of poor penetration through the blood-brain barrier. Whole-brain radiation therapy used to be a standard option for brain metastases.
5p vinatisu 29-08-2024 5 2 Download
-
To evaluate the efficacy of robotic video-assisted thoracic lobectomy (r-VATS) in patients with locally advanced non-small cell lung cancer. Subjects and methods: r-VATS lobectomy was performed in 79 patients with non-small cell lung cancer treated at Cho Ray Hospital from July 2018 to June 2022.
12p videadpool 06-05-2023 8 3 Download
-
Inhibitors targeting immune checkpoints, such as PD-1/PD-L1 and CTLA-4, have prolonged survival in small groups of non-small cell lung cancer (NSCLC) patients, but biomarkers predictive of the response to the immune checkpoint inhibitors (ICIs) remain rare.
19p vielonmusk 21-01-2022 15 1 Download
-
Numerous studies have examined catastrophic health expenditures (CHE) worldwide, mostly focusing on general or common chronic populations, rather than particularly vulnerable groups. This study assessed the medical expenditure and compensation of lung cancer, and explored the extent and influencing factors of CHE among households with lung cancer patients in China.
9p vielonmusk 21-01-2022 9 0 Download
-
We investigated the clinicopathological characteristics and survival of breast cancer lung metastases (BCLM) patients at initial diagnosis of metastatic breast cancer (MBC) in the Han population.
9p vielonmusk 21-01-2022 11 2 Download
-
Information-scores based on general inflammation markers are suggested as prognostic markers of overall survival (OS) in lung cancer. However, whether these inflammation-scores improves the prognostication per‑ formed by well-established prognostic markers is unsettled. In a large register-based lung cancer patient cohort, nine diferent inflammation-scores were compared, and their ability to optimize the prognostication of OS was evaluated.
10p vielonmusk 21-01-2022 13 1 Download
-
It has been postulated that patient’s sex impacts response to immunotherapy. Sex modulation of immunotherapy benefit, however, has not yet been explored using patient-level data, where potential confounder, as well as histologic type, can be accounted for. Here we investigated the association between sex and chemoimmunotherapy efficacy for non-small cell lung cancer (NSCLC) using a large, nation-wide dataset.
8p vielonmusk 21-01-2022 20 2 Download
-
Assessed the level of mRNA expression of CIZ1b, VEGF, EGFR mutations and the rate of Merkel cell infection in patients with non-small cell lung cancer. Assessed the level of mRNA expression of CIZ1b, VEGF, EGFR mutations and the rate of Merkel cell infection in patients with non-small cell lung cancer.
32p trinhthamhodang7 31-08-2020 33 3 Download
-
To describe the clinical and subclinical features of lung cancer patients with EGFR mutations before TKIs therapy and in the relapsed period. To identify the T790M mutation and MET amplification in patients with lung cancer and EGFR-TKIs resistance and the relationship with clinical and subclinical features.
29p cothumenhmong6 17-07-2020 12 2 Download
-
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
7p thulanh30 20-12-2011 39 3 Download